- Home
- PRPO vs FTFT Comparison
PRPO vs FTFT Comparison
Compare PRPO & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- FTFT
- Stock Information
- Founded
- PRPO N/A
- FTFT N/A
- Country
- PRPO United States
- FTFT United States
- Employees
- PRPO N/A
- FTFT N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- FTFT Business Services
- Sector
- PRPO Industrials
- FTFT Consumer Discretionary
- Exchange
- PRPO Nasdaq
- FTFT Nasdaq
- Market Cap
- PRPO 17.1M
- FTFT 5.4M
- IPO Year
- PRPO N/A
- FTFT N/A
- Fundamental
- Price
- PRPO $14.45
- FTFT $2.73
- Analyst Decision
- PRPO
- FTFT
- Analyst Count
- PRPO 0
- FTFT 0
- Target Price
- PRPO N/A
- FTFT N/A
- AVG Volume (30 Days)
- PRPO 17.7K
- FTFT 5.1M
- Earning Date
- PRPO 08-12-2025
- FTFT 08-18-2025
- Dividend Yield
- PRPO N/A
- FTFT N/A
- EPS Growth
- PRPO N/A
- FTFT N/A
- EPS
- PRPO N/A
- FTFT N/A
- Revenue
- PRPO $20,029,000.00
- FTFT $2,031,913.00
- Revenue This Year
- PRPO N/A
- FTFT N/A
- Revenue Next Year
- PRPO N/A
- FTFT N/A
- P/E Ratio
- PRPO N/A
- FTFT N/A
- Revenue Growth
- PRPO 26.67
- FTFT N/A
- 52 Week Low
- PRPO $3.90
- FTFT $1.01
- 52 Week High
- PRPO $16.89
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- PRPO 68.17
- FTFT 67.00
- Support Level
- PRPO $14.25
- FTFT $1.16
- Resistance Level
- PRPO $16.89
- FTFT $4.03
- Average True Range (ATR)
- PRPO 1.08
- FTFT 0.35
- MACD
- PRPO 0.24
- FTFT 0.23
- Stochastic Oscillator
- PRPO 67.57
- FTFT 68.38
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.